More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...
Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...
A next-generation biomarker-based blood test demonstrated 98% specificity and 75% sensitivity in detecting stage I and II pancreatic ductal adenocarcinoma, according to a press release from the ...
Blood tests can be an important part of a pancreatic cancer diagnosis. With this type of cancer, a timely diagnosis is vital, however, pancreatic cancer is often difficult to detect early. Certain ...
Please provide your email address to receive an email when new articles are posted on . The blood test reliably detected patients with stage I and II pancreatic ductal adenocarcinoma with 97% accuracy ...
Scientists are developing a test that uses a tiny blood sample to detect pancreatic cancer in its early stages. If caught early, pancreatic cancer can potentially be treated. However, patients usually ...